Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.
Subject Inclusion Criteria:
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Male or female patients
- All patients, 18 years of age or older
- Patient already on or added to the active waiting list for a single or bilateral lung transplant
- Patient or patient's representative provides informed consent for participation in the study at the time of study commencement or time of listing for transplant
- Patient or patient's representative reconfirms informed consent for the study on the day of lung transplant
Subject Exclusion Criteria:
A subject who meets any of the following criteria will be excluded from participation:
- Patients listed for same-side lung re-transplantation
- Patients listed for multiple organ transplantation including lung and any other organ
- Patients listed for live donor lobar transplant
- Patients with HIV, active Hepatitis B/C, or Burkholderia Cepacia
- Patients not initially consented into the study prior to the time of lung transplant
- Patients in the ICU at the time of initial lung offer requiring mechanical ventilation, ECMO or other Extracorporeal life support (ECLS).
Donor Lung Inclusion Criteria for EVLP Assessment:
The donor lung must meet at least one of the following criteria to proceed with EVLP:
- At the time of the clinical evaluation, the donor PaO2/FiO2 < 300 mmHg
- Donor received ≥ 10 units of blood transfusions
- Donation after Cardiac Death (DCD) donor
- Expected cold ischemic time > 6 hours
- Donor age ≥ 55 years old
- Study Center Investigator requires additional assessment ex vivo and/or extended preservation time
Donor Lung Exclusion Criteria for EVLP Assessment:
The donor lung is excluded from EVLP if at least one of the following criteria have been met:
- The donor lung has confirmed pneumonia and/or persistent purulent secretions identified via bronchoscopy
- Non-persistent purulent secretions that do not clear by hour 3 on EVLP
- The donor lung has confirmed evidence of aspiration
- The donor lung has significant mechanical lung injury or trauma
- The cold ischemic time, starting at donor aortic cross clamp/ initial flush (CIT-1), required to transport the lung from the donor site to start of the EVLP procedure at SPONSOR's facility > 10 hours
EVLP Lung Inclusion Criteria for Transplantation:
The donor lung must meet each of the following conditions post-EVLP for transplant suitability consideration by the Study Center Investigator:
- PvO2/FiO2 ≥ 350 mmHg at final EVLP evaluation time period
- and < 15% increase from baseline value (defined as the first hour collection point) to final value of pulmonary vascular resistance (PVR)
- and < 15% increase from baseline value to final value of peak airway pressure (PawP)
- and < 15% decrease from baseline value to final value of static lung compliance (Cstat)
- and the total preservation time (TPT) does not exceed the following:
- the initial CIT-1 time from donor to EVLP > 1 hour and ≤ 10 hours
- the EVLP time > 3 hours and ≤ 6 hours
- the second CIT-2 from EVLP cool down to beginning of recipient implantation must be > 1 hour and ≤ 6 hours for the first lung
- the second CIT-2 from EVLP cool down to beginning of recipient implantation must be > 1 hour and ≤ 10 hours for the second lung
- and Study Center Investigator deems lung function suitable for intended subject
EVLP Lung Exclusion Criteria for Transplantation:
The donor lung is excluded from transplant inclusion if at least one of the following criteria have been met:
- PvO2/FiO2 < 350 mmHg at final EVLP evaluation time period
- or ≥ 15% increase from baseline value to final value of pulmonary vascular resistance (PVR)
- or ≥ 15% increase from baseline value to final value of peak airway pressure (PawP)
- or ≥ 15% decrease from baseline value to final value of static lung compliance (Cstat)
- or TPT exceeds any of the following conditions:
- CIT-1 < 1 hour or > 10 hours
- EVLP < 3 hours or > 6 hours
- CIT-2 < 1 hour or > 6 hours for first lung or > 10 hours for second lung
- or Study Center investigator deems lung function unsuitable for intended subject